COCETTA, VERONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.498
AS - Asia 3.723
EU - Europa 2.367
SA - Sud America 670
AF - Africa 534
Continente sconosciuto - Info sul continente non disponibili 127
OC - Oceania 49
Totale 12.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.116
SG - Singapore 1.259
IT - Italia 935
CN - Cina 664
VN - Vietnam 531
BR - Brasile 434
HK - Hong Kong 349
FR - Francia 145
DE - Germania 141
PL - Polonia 138
FI - Finlandia 119
GB - Regno Unito 115
IN - India 114
SE - Svezia 110
BD - Bangladesh 108
CA - Canada 84
NL - Olanda 71
IQ - Iraq 65
UA - Ucraina 64
TR - Turchia 61
RU - Federazione Russa 51
MX - Messico 50
AR - Argentina 48
ID - Indonesia 44
ZA - Sudafrica 43
EC - Ecuador 41
JP - Giappone 39
PH - Filippine 39
ES - Italia 37
CZ - Repubblica Ceca 33
CH - Svizzera 32
IR - Iran 32
JM - Giamaica 31
MA - Marocco 29
PK - Pakistan 29
AT - Austria 27
VE - Venezuela 27
SA - Arabia Saudita 26
AZ - Azerbaigian 22
CO - Colombia 22
UZ - Uzbekistan 22
AE - Emirati Arabi Uniti 21
CR - Costa Rica 21
HR - Croazia 21
MY - Malesia 21
NP - Nepal 21
RS - Serbia 20
AU - Australia 19
IE - Irlanda 19
JO - Giordania 19
BZ - Belize 18
CL - Cile 18
CM - Camerun 18
CY - Cipro 18
IL - Israele 18
TH - Thailandia 18
UY - Uruguay 18
AO - Angola 17
BF - Burkina Faso 17
KE - Kenya 17
KR - Corea 17
LY - Libia 17
NI - Nicaragua 17
PT - Portogallo 17
PY - Paraguay 17
TJ - Tagikistan 17
TZ - Tanzania 17
AL - Albania 16
BJ - Benin 16
DZ - Algeria 16
EE - Estonia 16
GM - Gambi 16
GT - Guatemala 16
IS - Islanda 16
PE - Perù 16
TT - Trinidad e Tobago 16
EG - Egitto 15
ET - Etiopia 15
HU - Ungheria 15
LB - Libano 15
LU - Lussemburgo 15
PS - Palestinian Territory 15
RE - Reunion 15
RO - Romania 15
SD - Sudan 15
SI - Slovenia 15
SK - Slovacchia (Repubblica Slovacca) 15
BA - Bosnia-Erzegovina 14
BB - Barbados 14
BO - Bolivia 14
BY - Bielorussia 14
CU - Cuba 14
LV - Lettonia 14
MU - Mauritius 14
SN - Senegal 14
TN - Tunisia 14
BE - Belgio 13
DO - Repubblica Dominicana 13
GF - Guiana Francese 13
HN - Honduras 13
Totale 12.312
Salva come PNG Salva come JPEG
Città #
Singapore 749
Ashburn 719
San Jose 703
Hong Kong 306
Fairfield 291
Padova 236
Chandler 222
Santa Clara 197
Beijing 183
Ho Chi Minh City 178
Woodbridge 147
Cambridge 145
Ann Arbor 133
Seattle 131
Houston 124
Hanoi 123
Los Angeles 118
New York 105
Boardman 104
Wilmington 104
Bytom 89
Helsinki 86
Milan 76
Princeton 70
Medford 68
Lauterbourg 67
Munich 61
Des Moines 46
Rome 43
San Diego 38
Baghdad 36
São Paulo 36
Dallas 35
Da Nang 33
Buffalo 32
Orem 32
Warsaw 32
Atlanta 29
Council Bluffs 29
Montreal 28
Nanjing 27
Malo 26
Tokyo 26
Denver 25
Brooklyn 24
Amsterdam 23
Haiphong 23
Johannesburg 23
Chicago 22
Mexico City 22
The Dalles 22
Baku 21
Poplar 21
Roxbury 21
Tashkent 21
Chennai 20
Stockholm 20
Amman 19
Kingston 19
Phoenix 19
Redondo Beach 19
Turku 18
Frankfurt am Main 17
Guangzhou 17
Managua 17
Dublin 16
Montevideo 16
Palermo 16
Zagreb 16
Basingstoke 15
Istanbul 15
Manchester 15
San José 15
Ankara 14
Boston 14
Dakar 14
Dushanbe 14
Naples 14
Rio de Janeiro 14
Washington 14
Cagliari 13
Cotonou 13
Havana 13
London 13
Lugano 13
Nairobi 13
New Delhi 13
Ouagadougou 13
Quito 13
Reykjavik 13
Shanghai 13
Tallinn 13
Belgrade 12
Belo Horizonte 12
Biên Hòa 12
Bridgetown 12
Conakry 12
Dar es Salaam 12
Falkenstein 12
Lahore 12
Totale 6.990
Salva come PNG Salva come JPEG
Nome #
In Vitro Cultured Melissa officinalis Cells as Effective Ingredient to Protect Skin Against Oxidative Stress, Blue Light, and Infrared Irradiations Damages 360
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells 309
Polyoxometalates-peptides conjugates for cancer cell targeting: a structural investigation 280
Anti-senescence activity of Salvia haenkei on skin cellular model identified by integrated senescence-screening assay 280
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 271
Mitochondrial Involvement in Cisplatin Resistance 263
Peculiar combinations of individually non-pathogenic missense mitochondrial DNA variants cause low penetrance Leber’s hereditary optic neuropathy 261
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy 257
Further assessment of Salvia haenkei as an innovative strategy to counteract skin photo-aging and restore the barrier integrity 256
A fixed combination of probiotics and herbal extracts attenuates intestinal barrier dysfunction from inflammatory stress in an in vitro model using Caco-2 cells. 255
Identification of Salvia haenkei as gerosuppressant agent by using an integrated senescence-screening assay 250
Lindqvist polyoxovanadate-peptides conjugates for cancer cell targeting 237
Serenoa repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH) 231
Structural study of Lindqvist polyoxovanadate-peptide conjugates 216
Interaction between Mitochondrial DNA Variants and Mitochondria/Endoplasmic Reticulum Contact Sites: A Perspective Review 212
Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal Extracts in an In Vitro Model of Intestinal Epithelial Barrier Dysfunction 206
Protective effects of ψ taraxasterol 3-O-myristate and arnidiol 3-O-myristate isolated from Calendula officinalis on epithelial intestinal barrier 206
Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress 205
Milk kefir enriched with inulin-grafted seed extract from white wine pomace: chemical characterisation, antioxidant profile and in vitro gastrointestinal digestion 202
New insights in cisplatin-resistance: role of metabolic reprogramming in cancer cells 200
Anti-inflammatory activity of a fixed combination of probiotics and herbal extract in an in-vitro model of intestinal inflammation by stimulating Caco-2 cells with LPS-conditioned THP-1 cells medium 194
Silybin counteracts doxorubicin resistance by inhibiting GLUT1 expression 192
The SARS-CoV-2 spike protein binds and modulates estrogen receptors 189
Clinical evidence of interaction between nutraceutical supplementation and platinum-based chemotherapy 188
Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy 179
Retrospective Analysis of the Effect of Postmenopausal Women Medications on SARS-CoV-2 Infection Progression 176
Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2 176
Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives 168
Overcome cisplatin -resistance by targetin glucose-6-phosphate dehydrogenase with the combination of liposomal cisplatin and 6-amino nicotinamide 167
Anti-ageing activity of Salvia haenkei in an in vitro epidermal model 166
Study of metabolic reprogramming and identification of new pharmacological targets in chemotherapy resistance 163
Silybin as a new tool to counteract doxorubicin resistance by targeting glucose uptake 149
Plumbagin Induces Cell Cycle Arrest and Apoptosis in A431 Cisplatin-Resistant Cancer Cells 147
Novel Adenosine Triphosphate-Based Nutraceutical Formulation to Prevent Non-Steroidal Anti-Inflammatory Drug Enteric Cell Toxicity: Preliminary In Vitro Evidence 147
Mitochondrial phenotyping of doxorubicin-resistant osteosarcoma cells 147
Maintenance of intestinal epithelial barrier integrity by a combination of probiotics, herbal extract, and vitamins 145
Metabolic reprogramming in triple negative breast cancer cells: role of glutamine and glucose in cisplatin resistance 145
Anti-senescence activity of Salvia Haenkei on a skin cellular model 145
Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy 144
CHARACTERIZATION OF MITOCHONDRIAL METABOLISM OF DOXORUBICIN-RESISTANT OSTEOSARCOMA CELLS 143
Silybin, curcumin and quercetin as metabolic modulators in human resistant cancer cells 143
VALUTAZIONE DELL’ATTIVITA’ ANTI-INVECCHIAMENTO DELL’ESTRATTO AS PER APPLICAZIONE FITOCOSMETICA 141
Natural compounds as metabolic modulators in resistant cancer cells models 140
UN NAFTOCHINONE ESTRATTO DALLA PIANTA PLUMBAGO ZEYLANICA L. INDUCE MORTE CELLULARE DELLE CELLULE RESISTENTI AL CISPLATINO 139
Contribution of Mitochondrial Activity to Doxorubicin-Resistance in Osteosarcoma Cells 138
Role of mitochondria in cisplatin-resistance phenomena 137
Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses CisplatinResistance: new pharmacological approach using Cisplatin liposome and 6-amino nicotinamide combination 137
Mitochondria as cisplatin targets: new apporach to counteract resistance mechanism 136
VALIDAZIONE IN VITRO DI UNA COMBINAZIONE DI SERENOA REPENS E URTICA DIOICA PER LA TERAPIA DELL'IPERPLASIA PROSTATICA BENIGNA 136
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 135
Imbalance of mitochondrial "shaping proteins" and cisplatin resistance 134
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 134
Natural compounds as possible modulators of lipid metabolism in cisplatin-resistant cancer cells 133
Mitophagic/autophagic inhibitors as new strategy to overcome cisplatin resistance in cancer 132
Links between cancer metabolism and cisplatin resistance 131
Potential effect of Salvia Haenkey on in vitro wound healing 129
Targeting glucose-6-phosphate dehydrogenase by 6-amino nicotinamide in combination with liposomal cisplatin as a strategy to sensitize ovarian resistant cancer cells 129
Mitochondrial remodeling involved in cisplatin resistance 126
Curcumin and Cisplatin as new chemotherapeutic compounds in order to overcome cisplatin resistance 126
Cannabis Sativa modulates epithelial permeability in an in vitro intestinal inflammation model 124
Mitochondrial alterations involved in cisplatin resistance phenomena 122
IDENTIFICAZIONE DI ESTRATTI NATURALI CON PROMETTENTE APPLICAZIONE IN FITOCOSMESI 121
GLUTAMINE METABOLISM IN TRIPLE-NEGATIVE BREAST CANCER AND ITS ROLE IN CISPLATIN RESISTANCE 120
Lipid-metabolic reprogramming in ovarian carcinoma cell lines resistant to cisplatin 117
SILYBIN: A NATURAL COMPOUND ABLE TO OVERCOME DOXORUBICIN RESISTANCE PHENOMENA 116
Targeting glucose-6-phosphate dehydrogenase with a combination of liposomal cisplatin and 6-amino nicotinamide as new strategy to overcome cisplatin-resistance 115
Natural compounds as metabolic modulators in resistant cancer models 113
Natural polyphenol sensitize cancer cells to cisplatin effect on cell cycle 112
Calu-3 cells as in vitro model of bronchial epithelium for pharmacological studies of natural compounds 109
Synthesis of novel supramolecular selenomolybdate as anticancer agents: An experimental and DFT computational analysis 108
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 108
Silybin chemosensitize doxorubicin-resistant cells by targeting GLUT1 108
Antioxidant and anti-inflammatory activities of Cannabis Sativa in epithelial intestinal cell 99
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 99
Cannabis Sativa L. modulates epithelial permeability in an in vitro intestinal inflammation model 97
Natural compounds as metabolic modulators in resistant cancer cell models 91
Natural polyphenols as chemosensitizer: studies in resistant cancer cells. 78
Silybin glycolysis inhibitor as promising agent in chemotherapy 77
Sviluppo di un decongestionante nasale a base fitoterapica 76
Natural polyphenols chemosensitize cisplatin-resistant cells through cell cycle modulation 75
Totale 12.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.929
article - articoli 20.954
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 359
Totale 58.242
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022650 0 117 42 22 23 69 27 39 80 16 29 186
2022/2023598 129 46 21 36 120 59 6 32 80 3 47 19
2023/2024554 24 59 60 45 42 76 49 70 16 13 39 61
2024/20252.114 117 102 97 89 319 58 130 205 118 84 310 485
2025/20267.206 433 604 834 1.152 791 323 866 598 719 436 300 150
2026/2027477 268 209 0 0 0 0 0 0 0 0 0 0
Totale 12.968